FIELD: medicine.
SUBSTANCE: experimental thermochemotherapy treatment of tumours is ensured with introduction of magnetic antineoplastic preparation solution containing cytostatic agents. Then preparation is concentrated in tumour by exposure of inhomogeneous constant magnetic field followed by induction heating of tumour in variable magnetic field. After that tumour temperature is kept at +47 - +70°C. Then sphacelous tissues are removed using antiseptic solution. Cytostatic agents are introduced into metastasises.
EFFECT: higher life span in mammals, tumour debulking ensured with tumour tissue heating to such temperature at which cytostatic agents contained in magnetic preparation are activated thus invoking destruction of malignant membranes regardless of cell cycle phase.
4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING SOLID TUMORS BY APPLYING INDUCTIVE HYPERTHERMIA UNDER EXPERIMENTAL CONDITIONS | 2004 |
|
RU2291677C2 |
| METHOD OF FERRIMAGNETIC-THERMOCHEMOTHERAPY OF MALIGNANT TUMOURS WITH COMBINATIONS OF MAGNETOCONTROLLABLE NANOMEDICINES WITH VISUALISATION OF ONCOGENESIS, DETEMINATION OF THERAPY PREFERABLE IN REAL TIME MODE AND MONITORING OF TREATMENT RESULTS IN EXPERIMENT | 2014 |
|
RU2563369C1 |
| METHOD OF SUPPRESSION OF TUMOR GROWTH | 1996 |
|
RU2114623C1 |
| METHOD FOR INDUCTION HYPERTHERMIA IN EXPERIMENT | 2001 |
|
RU2203111C2 |
| METHOD FOR POTENTIATING ACTIVITY OF ANTI-TUMOUR CYTOTOXIC PREPARATIONS | 2017 |
|
RU2714140C2 |
| ANTITUMOR AGENT | 1999 |
|
RU2144821C1 |
| NEW CHEMICAL COMPOUND OF L-LYSINE 9-OXOACRIDINYL-10-ACETATE, STIMULATING PRODUCTION OF INTERLEUKIN-24 AND TUMOUR NECROSIS FACTOR - BETA | 2019 |
|
RU2730530C1 |
| PHARMACEUTICAL COMPOSITION BASED ON PALLADIUM COMPOUND | 2015 |
|
RU2613305C2 |
| MEANS TO INHIBIT TUMOR GROWTH | 1995 |
|
RU2106146C1 |
| N-[3-OXO-LUPANO-28-YL]-MORPHOLINE - AGENT FOR CORRECTION OF CYTOTOXIC LIVER DAMAGES WITH ANTITUMOUR AND ANTIMETASTATIC ACTIVITY | 2011 |
|
RU2461563C1 |
